Harbour Capital Advisors, LLC Novartis Ag Transaction History

Harbour Capital Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 08, 2020	SELL	$70.67 - $99.01 $374,056 - $524,059	-5,293 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$84.35 - $95.37 $446,464 - $504,793	5,293 New	5,293 $501,000
Q2 2019 Jul 10, 2019	SELL	$75.4 - $92.8 $317,660 - $390,966	-4,213 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$75.32 - $86.15 $2,410 - $2,756	-32 Reduced 0.75%	4,213 $405,000
Q4 2018 Jan 23, 2019	SELL	$73.66 - $82.02 $8,102 - $9,022	-110 Reduced 2.53%	4,245 $364,000
Q3 2018 Nov 07, 2018	SELL	$66.94 - $77.43 $5,020 - $5,807	-75 Reduced 1.69%	4,355 $375,000
Q2 2018 Jul 11, 2018	SELL	$64.91 - $73.36 $4,868 - $5,502	-75 Reduced 1.66%	4,430 $331,000
Q1 2018 Apr 18, 2018	BUY	$70.39 - $84.15 $30,619 - $36,605	435 Added 10.69%	4,505 $364,000
Q4 2017 Jan 24, 2018	BUY	$72.33 - $77.64 $19,167 - $20,574	265 Added 6.96%	4,070 $342,000
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $282,102 - $294,012	3,805	3,805 $327,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbour Capital Advisors, LLC with notifications on news.